A Phase 3, Randomized, Open-Label Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Adults > 65 Years of Age with Prior Pneumococcal Vaccination

Grants and Contracts Details

StatusFinished
Effective start/end date1/30/193/18/20

Funding

  • ICON Clinical Research: $6,499.00